US nutrition startup Berry Street merges with India’s Healthify as GLP-1 trends upwards
U.S.-based Berry Street and India's Healthify have merged to create a global platform focused on metabolic care and GLP-1 weight-loss drug support. The new entity will leverage AI-driven coaching and a network of clinicians to scale services.
Why it matters
The merger highlights the rapid growth of the GLP-1 market and the increasing integration of AI and clinical services in the digital health sector.
U.S. nutrition startup Berry Street said on Monday it has merged with Khosla Ventures-backed Indian startup Healthify to bank on the popular trend of people turning to GLP-1 drugs to lose weight.
The companies didn’t disclose the financial details of the deal. A report from JP Morgan published this year suggested that over 30 million people in the U.S. will be on GLP-1 by 2030 .
The companies said Berry Street founder Noah Kotlove and Healthify founder Tushar Vashisht will act as co-CEOs of the new entity. In the U.S., the company will operate under the Berry Street banner, and in other markets like India, it will operate under the Healthify brand.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in